lipid.siteBempedoic acid (Nexletol)
What clinical trials found
ATP-citrate lyase (ACL) inhibitor
Oral, once-daily pill, often used for statin-intolerant patients since it's not associated with the muscle-related side effects statins can cause. Approved 2020. CLEAR Outcomes showed reduced cardiovascular events in statin-intolerant patients.
CLEAR OutcomesBempedoic acid (Nexletol)
0 community reports (cases written by lipid.site are not counted)
Not enough shared yet (N = 0). Community numbers appear once enough people have shared.
Related topics: Statin intolerance
Compare this drug against another